siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS

Anticancer Research

Volumn 23, Issue 3 A, 2003, Pages 1997-2005

  Akkina, Ramesh ^a   Banerjea, Akhil ^a   Bai, Jirong ^b   Anderson, Joseph ^a   Li, Ming Jie ^c   Rossi, John ^c  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

HIV gene therapy; Lentiviral vectors; Ribozymes; siRNAs; Stem cells

Indexed keywords

CD34 ANTIGEN; LENTIVIRUS VECTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CHEMOKINE RECEPTOR CCR5 RIBOZYME; RETROVIRUS VECTOR; REV PROTEIN; RIBOZYME; RNA; RNA DECOY; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CELL BASED GENE THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; GENE CONSTRUCT; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; SCID MOUSE; STEM CELL; T LYMPHOCYTE; TRANSGENE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; BASE SEQUENCE; GENE THERAPY; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACID CONFORMATION; RNA, CATALYTIC; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSDUCTION, GENETIC;

EID: 0041304776     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Piot P, Bartos M, Ghys PD, Walker N and Schwartlander S: The global impact of HIV/AIDS. Nature 410: 968-973, 2001.
2. Nabel GJ: Challenges and opportunities for development of an AIDS vaccine. Nature 410: 1002-1007, 2001.
3. Richman DD: HIV chemotherapy. Nature 410: 995-1001, 2001.
4. Amado RG and Chen IS: Lentiviral vectors-the promise of gene therapy within reach? Science 285: 674-676, 1999.
5. Verma IM and Sonia N: Gene therapy-promises, problems and prospects. Nature 389: 239-242, 1997.
6. Joshi S, Brunschot AV, Asad S, Van der Elst I, Read SE and Bernstein A: Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J Virol 65: 5524-5530, 1991.
7. Zhou C, Bahner I, Larson GP, Zaia JA and Rossi JJ and Kohn DB: (1994). Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149: 33-39, 1994.
8. Rossi JJ: The application of ribozymes to HIV infection. Curr Opin Mol Ther 1: 316-322, 1999.
9. Unwalla H and Banerjea AC: Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA-enzymes targeted to cleave HIV-1 TAT/Rev RNA. Biochemical J 357: 97-105, 2001.
10. Santoro SW and Joyce GF: A general purpose RNA-cleaving DNA-enzyme. Proc Natl Acad Sci USA 94: 4262-4266, 1997.
11. Bahner I, Kearns K, Qian-Lin H, Smogorzewska M and Kohn DB: Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J Virol 70: 4352-4360, 1996.
12. Bonyhadi ML, Moss K, Voytovich A, Auten J, Kalfoglou C, Plavec I, Forestell S, Su L, Bohnlein E, and Kaneshima H: RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol 71: 4707-4716, 1997.
13. Amado RG, Mitsuyasu RT and Zack JA: Gene therapy for the treatment of AIDS: animal models and human clinical experience. Front Biosci 4: D468-475, 1999.
14. Weissman IL: Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287: 1442-1446, 2000.
15. Logan AC, Lutzko C and Kohn DB: Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr Opin Biotechnol 13: 429-436, 2002.
16. Akkina RK, Rosenblatt JD, Campbell AG, Chen ISY and Zack JA: Modeling human lymphoid precursor cell gene therapy in the SCID-hu mice. Blood 84: 1393-1398, 1994.
17. Bai J, Gorantla S, Banda N, Cagnon L, Rossi JJ and Akkina RK: Characterization of Anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo. Molecular Therapy 1: 244-254, 2000.
18. Bai J, Rossi JJ and Akkina R: Multi-valent anti-CCR5 ribozymes for stem cell based HIV-1 gene therapy. AIDS Research & Human Retroviruses 17: 385-399, 2001.
19. Bai J, Banda N, Lee NS, Rossi JJ and Akkina R: RNA based anti-HIV-Igene therapeutic constructs in SCID-hu mouse model. Mol Therapy 6: 770-782, 2002.
20. Berger EA, Murphy PM, and Farber JM: Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Ann Rev Immunol 17: 657-700, 1999.
21. Cech TR: The chemistry of self-splicing RNA and RNA enzymes. Science 236: 1532-1539, 1987.
22. Miller AD and Rossman J: Improved retroviral vectors for gene transfer and expression. Bio Techniques 7: 980-990, 1989.
23. McCune JM: The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974-979, 2001.
24. Emerman M and Malim MH: HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280: 1880-1884, 1998.
25. Akkina RK, Walton RM, Chen ML, Li QX, Planelles V and Chen IY: High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 70: 2581-2585, 1996.
26. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
27. Sharp PA: RNA interference, 2001. Genes & Development 15: 485-490, 2001.
28. Coburn GA and Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76: 9225-9231, 2002.
29. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P and Rossi J: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20: 500-505, 2002.
30. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee S-K, Collman RG, Lieberman J, Shankar P and Sharp PA: siRNA-directed inhibition of HIV-1 infection. Nature Medicine 8: 681-686, 2002.
31. Jacque JM, Triques K and Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature 418: 379-380, 2002.
32. Pomerantz RJ: RNA interference meets HIV-1: will silence be golden? Nature Medicine 8: 659-660, 2002.
33. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D and Naldini L: A third generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471, 1998.
34. Kimpton J and Emerman M: Detection of replication-competent and pseudotyped Human Immunodeficiency Virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66: 2232-2239, 1992.
35. Kohn DB, Bauer G, Rice CR, Rothschild JC, Carbonaro DA, Valdez P, Hao QL, Zhou C, Bahner I, Kearns K, Brody K, Fox S, Haden E, Wilson K, Salata C, Dolan C, Wetter C, Aguilar-Cordova E and Church J: A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 94: 368-371, 1999.
36. Jamieson BD and Zack JA: Murine models for HIV disease. AIDS 13: S5-S11, 1999.
37. Ziegler BL, Valtieri M, Almeida G, Porada GA, De Maria R, Müller R, Masella B, Gabbianelli M, Casella I, Pelosi E, Bock T, Zanjani ED and Peschle C: KDR receptor: A key marker defining hematopoietic stem cells. Science 285: 1553-1558, 1999.
38. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, Lulli V, Marziali G, Masella B, Muller R, Sgadari C, Testa U, Bonanno G and Peschle C: Identification of the hemangioblast in postnatal life. Blood 100: 3203-3208, 2002.